Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05946486 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.

Name: Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity. — clinical trial record (NCT05946486)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TIM-DePisT

StatusNot Yet Recruiting

PhasePhase 3

SponsorUniversity Hospital, Bordeaux

Started2023-10-15

View on ClinicalTrials.gov ↗

Record status

This record was last updated July 14, 2023 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.

University Hospital, Bordeaux

458 trials monitored

See 6 trials at risk

This is an open phase III randomized clinical trial studying the superiority of management by immunomodulator treatment of psychiatric disorders (psychosis and bipolar disorders) for patients previously identified as carriers of autoimmunity such as as the presence of a pathogenic anti-glutamatergic NMDA receptor antibody (NMDAr-Ac).

Trial Details

NCT Number	NCT05946486
Lead Sponsor	University Hospital, Bordeaux
Conditions	Mental Disorder
Enrollment	174 participants
Start Date	2023-10-15
Primary Completion	2026-01-15 (estimated)
Study Completion	2026-12-15 (estimated)
Updated on ClinicalTrials.gov	2023-07-14